Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19.

Julio CollazosPere DomingoNerio Fernández-AraujoElia Asensi-DíazHelem Vilchez-RuedaAntonio LaluezaEmilia Roy-VallejoMarino Blanes-JuliáManuel Raya-CruzJaime Sanz-CánovasArturo ArteroJosé-Manuel Ramos-RincónCarlos Dueñas-GutiérrezJosé Luis Lamas-FerreiroVíctor Asensinull null

Published in: PloS one (2022)

VPA-treated patients seem to develop less serious COVID-19 than control patients, according to diverse clinical endpoints and laboratory markers.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
coronavirus disease
sars cov
prognostic factors
patient reported outcomes
patient reported